UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 466.1 EUR -4.33%

Market Cap: €13.2B

U	United Therapeutics Corp SWB:UTH	US
P	PennyMac Mortgage Investment Trust F:8PM	US
L	Lubelski Wegiel Bogdanka SA XMUN:UXX	PL
	Fresh Del Monte Produce Inc NYSE:DMC	KY
	Reconnaissance Energy (Africa) Ltd F:0XD	CA
	Premier Investments Ltd ASX:PMV	AU
	Saga Communications Inc F:SGHB	US
Z	Zymeworks Inc F:ZA8	US

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

90% > 87%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

52% > 45%

Exceptional Net Margin

41%

Strong 3Y Average Net Margin

41%

Declining Net Margin

41% > 41%

Exceptional Free Cash Flow Margin

32%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

32% > 32%

Positive ROE

20%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.